Treatment of Locally Advanced Esophageal Carcinoma
Publication Date: July 28, 2021
Key Points
Key Points
- Esophageal cancer is the 6th most common cancer worldwide, with an estimated 450,000 deaths per year.
- Multimodality therapy for patients with locally advanced esophageal carcinoma is recommended.
- For the subgroup of patients with adenocarcinoma, preoperative chemoradiotherapy or perioperative chemotherapy should be offered.
- For the subgroup of patients with squamous cell carcinoma, preoperative chemoradiotherapy or chemoradiotherapy without surgery should be offered.
Treatment
Treatm...
...modality therapy should be offered to patient...
...perative chemoradiotherapy (CRT) or per...
...RT or CRT without surgery (definitive CRT) shou...
...mentFor patients with esophageal squamous cell c...
...CO Recommendation Update – August...
...owing neoadjuvant CRT and surgery, nivolumab sh...